MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
FILANA THERAPEUTICS, INC. (FLNA)
FILANA THERAPEUTICS, INC. (FLNA)
source: myfinsight.com
Net decrease in cash
and cash...
-$8,929K
Stock-based compensation
$4,069K
Prepaid and other
current assets
-$867K
Depreciation and
amortization
$243K
Accrued development
expense
$241K
Net cash used in
operating activities
-$8,878K
Net cash (used in)
provided by financing...
-$51K
Canceled cashflow
$5,420K
Net loss
-$10,331K
2025 atm program
offering costs
$51K
Accounts payable and
accrued expenses
-$2,458K
Accrued compensation
and benefits
-$1,379K
Other liabilities
-$130K
Back